SEC Form 4 · accession 0001209191-18-049644
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernie Meyer
Officer — EVP and CHRO
Period of report
Aug 31, 2018
Accepted (ET)
Sep 5, 2018 · 6:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 31, 2018 | A | 30,000 | $0.00 | A | 30,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $29.85 | Aug 31, 2018 | A | 87,500 | A | — | Aug 30, 2028 | Common Stock | 87,500 | 87,500 | D |
Explanation of responses
- F1Grant of Restricted Stock Units ("RSUs") in consideration of services rendered. The RSUs will vest annually over three years commencing on September 1, 2019, subject to the Reporting Person's Continuous Service as of each such date.
- F2The Option vest as follows: 25% of the shares shall vest one year from the Vesting Commencement Date of August 20, 2018, and the remaining shares shall vest ratably over the next 36 months.